Citius Pharmaceuticals Inc (CTXR NASDAQ) stock market data APIs
$2.2299
-0.15(-6.7%)
as of July 3, 2025
Try our APIs with
free plan!
Citius Pharmaceuticals Inc Financial Data Overview
Price chart is built with
Anychart
Citius Pharmaceuticals, Inc., a biopharmaceutical company, focuses on the development and commercialization of critical care products. Its LYMPHIR, an FDA approved product, is a targeted immunotherapy for the treatment of cutaneous T-cell lymphoma. The company's late-stage pipeline includes Mino-Lok, an antibiotic lock solution to salvage catheters in patients with catheter-related bloodstream infections; and CITI-002 (Halo-Lido), a topical formulation for the relief of hemorrhoids. The Pivotal Phase 3 Trial for Mino-Lok and a Phase 2b trial for Halo-Lido completed. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.
Prev. Close
2.2299
Open
2.0761
High
2.4982
Low
1.9907
52 wk Range
0.65-26.25
Market Cap
24 696 K
Shares Outstanding
10 830 K
EPS
-1.27
Beta
0.852
Why to choose EODHD?
Prices start at $19.99
24/7 Live support
Robust, powerful and reliable data
API Simplicity of a few lines of code
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
Get Citius Pharmaceuticals Inc data using free add-ons & libraries
Get Citius Pharmaceuticals Inc Fundamental Data
Citius Pharmaceuticals Inc Fundamental data includes:
- Net Revenue:
- EBITDA: -42 983 960
- Earnings Per Share:
- Income Statements
- Balance Sheets
- Cash flows
Plans with Fundamental data
Starting from
$
59.99
/mo.
End-of-day & Earnings data
What’s included:
- Latest Release: 2025-05-12
- EPS/Forecast: 0.11
What’s included:
- End of Day, Intraday and Live APIs
- Splits
- Dividends
Citius Pharmaceuticals Inc News
New
Citius Pharmaceuticals announces registered direct offering of $15.8 million
Citius Pharmaceuticals (NASDAQ:CTXR [https://seekingalpha.com/symbol/CTXR]) announced on Tuesday that it has entered into definitive agreements for the purchase of an aggregate of 4.92 million shares ...
Citius Oncology enters distribution services agreement with Cardinal Health
Citius Oncology (NASDAQ:CTOR [https://seekingalpha.com/symbol/CTOR]), the oncology-focused subsidiary of Citius Pharmaceuticals (NASDAQ:CTXR [https://seekingalpha.com/symbol/CTXR]), has entered into a...
Citius Oncology Enters into Distribution Services Agreement with Cardinal Health
Agreement supports the upcoming launch of LYMPHIR for the treatment of cutaneous T-cell lymphoma CRANFORD, N.J., June 9, 2025 /PRNewswire/ -- Citius Oncology, Inc. ("Citius Oncology") (Nasdaq: CTOR)...
Bucking the Trend: 3 Stocks That Zoomed While the Market Crashed
It is starting to look like last week’s market meltdown was not the beginning of a broad-based collapse. Although fear of a U.S. recession, concern over the melt-up in AI-powered tech stocks and the...
Try our APIs
with free plan!
Or get access to advanced financial data starting only $19.99
TRY NOW
- Flexibility: No long-term commitments, just a minimum of one month
- Instant access: Get your API key and instructions within seconds of subscribing
- Price stability: Locked-in rates for subscribed users, never changing
All-In-One
$99.99/mo.
What’s included:
- API Calls per Day: 100 000/day
- API Requests per Min.: 1000/minute
- Type of Usage: Personal use
Data access:
Historical EOD, Fundamental, Real-Time, Intraday, Live (Delayed), Technical & Screener APIs, News Feed, 40 000 Stock Logos and many more. See a full list.
